Project Management Playbook to Effective Stakeholder Management
In this session you will learn why the ability to identify and manage key stakeholders is critical for the success of a project. The basic concepts of stakeholder management will be discussed along with specific examples on how to apply stakeholder management strategies.In this session you will learn why the ability to identify and manage key stakeholders is critical for the success of a project. The basic concepts of stakeholder management will be discussed along with specific examples on how to apply stakeholder management strategies.
Session Chair(s)
Sandra Elizabeth Gallagher, MS, PMP
Director of Project Management
Viela Bio, United States
Sandra Gallagher has over 13 years of experience in early and late stage drug development. She is currently a portfolio and program manager developing global clinical strategies on cross-functional teams and managing alliances. Ms. Gallagher received her M.S. degree from the University of Maryland, Baltimore and has an extensive background in research and development. Most recently she is working to establish the PMO organization at a small-biotech company, Viela Bio.
Speaker(s)
Sandra Elizabeth Gallagher, MS, PMP
Director of Project Management
Viela Bio, United States
Sandra Gallagher has over 13 years of experience in early and late stage drug development. She is currently a portfolio and program manager developing global clinical strategies on cross-functional teams and managing alliances. Ms. Gallagher received her M.S. degree from the University of Maryland, Baltimore and has an extensive background in research and development. Most recently she is working to establish the PMO organization at a small-biotech company, Viela Bio.
Dwayne Stanley, MBA
Sr. Director, Program Management
Vigil Neuroscience, United States
Dwayne Stanley is a Program Leadership professional who partners with cross-functional teams to design, develop and deliver products within the medical device and pharmaceutical industries. After spending almost two decades in the medical device industry, Dwayne transitioned to the biotech/pharmaceutical industry in 2019. He has expanded his breadth of knowledge in the area of launching drug products aimed at improving the quality of life for patients with cancer and other serious diseases through novel epigenetic medicines. Most recently, Dwayne has transitioned to Kaleido Biosciences, as their Director of Program Management, running programs that target the microbiome to treat disease and improve human health.